Efficacy of ketamine intervention to decrease alcohol use, cravings, and withdrawal symptoms in adults with problematic alcohol use or alcohol use disorder: A systematic review and comprehensive analysis of mechanism of actions
Garel N, McAnulty C, Greenway KT, Lesperance P, Miron JP, Rej S, Richard-Devantoy S, Jutras-Aswad D., Drug and Alcohol Dependence, 2022
Buprenorphine/naloxone and methadone effectiveness for reducing craving in individuals with prescription opioid use disorder: Exploratory results from an open-label, pragmatic randomized controlled trial
McAnulty C, Bastien G, Eugenia Socias M, Bruneau J, Le Foll B, Lim R, Brissette S, Ledjiar O, Marsan S, Talbot A, Jutras-Aswad D; OPTIMA Research Group within the Canadian Research Initiative in Substance Misuse., Drug Alcohol Depend. 2022
The tobacco-free fallacy: What paediatricians should know about herbal smoking products
Khorasani A., Chadi N., Paediatrics & Child Health, 2022
Social service providers’ perspectives on caring for structurally vulnerable hospital patients who use drugs: a qualitative study
Gehring ND, Speed KA, Dong K, Pauly B, Salvalaggio G, Hyshka E. , BMC Health Serv Res. 2022
Navigating Opioid Agonist Therapy among Young People who use Illicit Opioids in Vancouver, Canada
Pilarinos A, Kwa Y, Joe R, Thulien M, Buxton JA, DeBeck K, Fast D., Int J Drug Policy. 2022
The practice and embodiment of “goofballs”: A qualitative study exploring the co-injection of methamphetamines and opioids
Ivsins A, Fleming T, Barker A, Mansoor M, Thakarar K, Sue K, McNeil R., Int J Drug Policy. 2022
Supporting Self-isolation for COVID-19 With “Risk Mitigation” Prescribing and Housing Supports for People Who Use Drugs: A Case Report
Hong RH, Brar R, Fairbairn N., J Addict Med. 2022
Public health approaches to substance use: a scoping review protocol
Kosteniuk B, Speed K, Candler E, Campbell S, Penney G, Moen K, Hyshka E. , JBI Evid Synth. 2022
Office-based Methadone Prescribing for Opioid Use Disorder: The Canadian Model
Kleinman RA, Brothers TD, Danilewitz M, Bahji A., J Addict Med. 2022
Barriers and facilitators to opioid agonist therapy in rural and remote communities in Canada: an integrative review
Pijl, E.M., Alraja, A., Duff, E., Cooke, C., Dash, S., Nayak, N., Lamoureaux, J., Pouline, G., Knight, E., Fry, B., Subst Abuse Treat Prev Policy. 2022
